Invitation to the Presentation of Paxman’s Q2 Report on 20 August
Paxman will publish the Q2 report for the period April-June on 20 August 2025 at 07:00 CET.
A live broadcast presentation for investors, analysts and media will be held on the same day at 09:00 CET.
During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova, Equity Research Analyst at Carnegie. The presentation will be held in English.
How to join
To participate in the digital presentation, advance registration is required. Please register using the following link: https://qcnl.tv/p/8ZJa_ZnzuFHtWf33OYhugw
Once registered, you will receive a confirmation email shortly to access the presentation.
Contacts
Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se
About Us
The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 6,000 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK), Houston, Texas (US) and Toronto, Ontario (CA).
The PAXMAN share is listed on Nasdaq First North Growth Market.
FNCA Sweden AB is the company’s Certified Adviser.
Bifogade filer